Standards, Guidelines, and Regulations
|
|
- Antonia Cox
- 5 years ago
- Views:
Transcription
1 Standards, Guidelines, and Regulations Theresa C. Stec BA, MT(ASCP) Biovigilance Program Manager Surgical System Administrator Perioperative Services Baystate Medical Center Springfield, MA
2 Standards, Guidelines, and Regulations percent QIA* Exam content in following subjects A. Informed Consent B. Confidentiality C. Donor Selection D. Facility Licensure and Accreditation E. Training and Competency ASFA, AABB, CAP, FDA, FACT, HIPAA, TJC, etc. *Qualification in Apheresis Exam, offered by ASCP
3 Learning Objectives To provide an overview of the following topics Informed Consent Confidentiality Donor Selection Training and Competency Facility Licensure and Accreditation
4 Ultimate Goal Public Safety including the safety of patients, the blood supply both donors who donate products and patients who receive products, and the healthcare workers responsible for all aspects of procuring, processing, testing and releasing products.
5 Informed Consent The basic required elements of informed consent can be found in the HHS regulations at 45 CFR (a). OHRP also has a tips sheet for informed consent available at
6 Informed Consent Written consent is obtained before the procedure and on the day of donation. Elements include, Explanation of procedure in understandable terms/ language, Explanation about the risk of procedure, Tests performed for transmission of infectious diseases and requirements to report donor information/ test results to public health departments, Opportunity to ask questions and receive answers Opportunity to give or to refuse consent, For minor or legally incompetent adult follow applicable laws.
7 Health Insurance Portability and Accountability Act HIPAA The HIPAA Privacy Rule requires that covered entities apply appropriate administrative, technical, and physical safeguards to protect the privacy of protected health information (PHI), in any form. See 45 CFR (c).
8 Health Insurance Portability and Accountability Act HIPAA Protected health information (PHI) Information accessed only for treatment, payment, healthcare operations, as authorized in writing by patient and circumstances described in privacy rules PHI created in any medium, written, oral or electronic Demographic information that can identify someone Past, Present or Future information related to physical or mental health conditions Payment for health care Law enforcement, public health, FDA adverse event reporting, research
9 FDA Part 640.3: Suitability of Donor Determined by a qualified physician or by persons under his supervision and trained in determining suitability Determined on the day of collection by Means of medical history A test for hemoglobin level Physical examination as appears necessary to physician
10 FDA Part 640.3: Suitability of Donor Qualification of donor in good health Not a source of whole blood in last 8 weeks or double RBC in 16 weeks Normal temperature Systolic & diastolic blood pressure within normal limits Note: On site physician may qualify blood pressure Hemoglobin no less than 12.5 grams (38% HCT)
11 FDA Part 640.3: Suitability of Donor Freedom from acute respiratory diseases Freedom from any infectious skin disease at site of phlebotomy (risk of contamination of product) Freedom from any disease transmissable by blood Freedom of the arms and forearms from skin punctures or scars indicative of addition to selfinjected narcotics
12 FDA Part 640.3: Suitability of Donor No history of viral hepatitis (> age 11) No history within 12 months of donation of close contact with individual having viral hepatitis of receiving human blood or any derivatives
13 FDA Part 640.3: Suitability of Donor Qualifications; donations within less than 8 weeks. If at the time of donation the person is examined and certified by a physician to be in good health as indicated in the Qualification of donor in good health section
14 FDA Part 640: Subpart C-Platelets Suitability of donor Plateletpheresis donors must meet the criteria as described in Suitability of donor Or as described in an approved biologics license application (BLA) or an approved supplement to a BLA Informed consent must be obtained (640.61) Medical supervision (640.62)
15 If it s not documented it didn t happen
16 Training Key component to quality is training. Training program includes Written objections (competency based) Written training plan Documentation of training and competency assessment tools Checklist Direct observations Test of knowledge/ skills Critical thinking/ troubleshooting Continuing education Corrective action plan/ re-training
17 Competency Assessment Assessment of competence performed before independent performance of assigned activities and at specified intervals.
18 Competency Assessment Administration of a Written Evaluation: Written evaluations for verification of a participant s knowledge. Knowledge of theory or principles, problem-solving ability, logical sequence used, and independent or group decision making. Observation of Procedure, Process, or Outcome: Observation by a trainer of an employee performing task.
19 Competency Assessment Verification of Response to Situational Problems or Calculations Related to the Procedure: What would you do if A procedure-related situational problem or recommendation of procedure-related course of action that is consistent with policies and regulations. Response to Oral Queries Related to a Step or Procedure: Answers provided by the employee to questions asked by trainer.
20 Competency Assessment Wet Testing Testing Blind QC Samples: Employees are unaware when blind test samples are assigned. They appear identical to other samples Testing of Known Samples: External proficiency surveys and commercially prepared quality control samples. Participants know and often plan for such testing events. This competency is assigned and rotated to all staff on all shifts.
21 Competency Assessment Testing Previously Analyzed Samples: Duplicate or replicate testing provides comparisons and contributes to the validation of the analytical phase. Sources may be previously tested samples run at pre determined intervals, samples of known constituents (spiked sample), or already reported proficiency testing samples.
22 Food and Drug Administration FDA Registration Human blood components regulated as drug and biologic Title 21 of Code of Federal Regulations(CFR), Part 640 Facilities collecting products for transfusion must register Blood Establishment & Product Listing: Form FDA 2830 Registrants subject to inspection every two years. Registrants must comply with CFRs, cgmp, and cgtp Registered, non-licensed facilities number must appear on components label as part of facilities identification
23 Food and Drug Administration FDA Registration Tissue Establishment & Product Listing: Form FDA 3356 Human Cells, Tissues, and Cellular & Tissue Based Products (HCT/Ps) At the beginning of each inspection, a Form FDA-482, Notice of Inspection, should be issued to the most responsible individual available at the HCT/P establishment. At the close of the inspection, observations focusing on the requirements of 21 CFR Part 1271, should be listed on a Form FDA-483 and issued to the most responsible individual.
24 Food and Drug Administration Inspection of HCT/P Current good tissue practice (CGTP) regulations ten core requirements [21 CFR (b)]: 1. Donor requirements relating to: Donor eligibility determinations, 21 CFR Donor screening, 21 CFR Donor testing in 21 CFR , and Facilities requirements in 21 CFR (a) and (b) 3. Environmental Controls requirements in 21 CFR (a) 4. Equipment requirements in 21 CFR (a) 5. Supplies and Reagents requirements in 21 CFR (a) and (b)
25 Food and Drug Administration 6. Recovery requirements in 21 CFR Processing and Process Controls requirements in 21 CFR Labeling controls requirements in 21 CFR (a) and (b) 9. Storage requirements in 21 CFR (a) through (d) 10. Receipt, predistribution shipment, and distribution requirements of an HCT/P in 21 CFR (a) through (d). COMPLIANCE PROGRAM GUIDANCE MANUAL. Inspection of Human Cells, Tissues, and Cellular and Tissue-Based Products (HCT/Ps)
26 Licensure FDA Licensure To engage in interstate commerce of biological products Complete Form FDA 356h for biologic license application (BLA) Submit supporting documentation as directed Approval of BLA indicates both establishment and products meet requirements Contact FDA for requirements for your facility and products
27 Regulatory Agencies Department of Health and Human Services (HHS) Food and Drug Administration (FDA) Centers for Medicare and Medicaid Services (CMS) Office of Civil Rights Center for Biologics Evaluation and Research (CBER) Public Health Service (PHS) HIPAA Department of Labor Occupational Safety and Health Administration (OSHA) Department of Transportation Shipping of products
28 Accreditation Agencies AABB Foundation for the Accreditation of Cellular Therapy (FACT) The Joint Commission (TJC) College of American Pathologists (CAP)
29 Why Accreditation? Assesses quality systems and operational areas for compliance with organization s standards. Assists in preparation for other inspections, and serves as an external audit providing a valuable tool to improve both compliance and operations. Offers both educational and peer review opportunities.
30 Inspections Who can inspect? FDA: Form FDA-482, Notice of Inspection AABB FACT (Stem Cell Facilities) Joint Commission Center for Medicaid and Medicare Services (CMS) CAP (College American Pathologists) CLIA/OSHA State and local agencies (Public Health)
31 Your Facility AABB/ CAP/ FACT TJC DPH CMS FDA
32 Parts: FDA Regulations Title 21 CFR 210, 211: cgmp (Drugs) 600, 601, 610: Biological Products 606: cgmp for Blood and Blood Component 607: Establishment Registration 630, 640: Requirements for Blood, Blood Component and Blood Derivatives 660: Diagnostic Substances for Laboratory Tests 820: Quality System
33 FDA Regulations (continued) Title 21 CFR Parts: 1270: Human Tissue Intended for Transplantation 1271: Human Cells, Tissues, and Cellular & Tissue Based Products Title 42 CFR Part 493: Laboratory Requirements FDA web site Search CFR Title 21 Database
34 FDA Quality System Requirements (QSR) Quality policy: commitment to quality by management with executive responsibility to ensure that quality policy is- 1. Understood 2. Implemented 3. Maintained at all levels of the organization
35 FDA QSR (Continued) Management representative documented authority over and responsibility for- 1. QSR established and maintained 2. Report performance of quality system 3. Review suitability and effectiveness at defined intervals with sufficient frequency to ensure QSR are satisfied 4. Documents results and dates of quality system reviews (820.20)
36 FDA QSR (Continued) Quality system procedures: outline of the structure of the documentation used in the quality system (820.20e) Quality audit: procedures to conduct audits to assure compliance with QSR and determine effectiveness of quality system Quality audits shall be conducted by individuals who do not have direct responsibility for matters being audited.
37 Current Good Manufacturing Practice (cgmp) 21 CFR Part : Definitions Processing means any procedure employed after collection, and before or after compatibility testing of blood Includes unit ID, components made, serological testing, labeling and associated records Control means having responsibility for maintaining the continued safety, purity, and potency of the product Distributed means the blood or blood components have left the control of The licensed manufacturer, Unlicensed registered blood establishment, or Transfusion service or, Licensed manufacturer has provided product for use in manufacture of a licensed biological product
38
39
40 Universal Protocol TIME OUT Performed immediately before invasive procedure Verify correct: patient, procedure & site Should involve patient or patient advocate (RN) Consider performing Time Out for any procedure that your facility requires a separate informed consent be obtained.
41 TRACER METHOD The Joint Commission Follow patient/ chart through various services Transfusion/ Transplant Follow product from storage to patient Follow adverse event back to processing Processing / Testing Follow supplies to results Follow product to storage
42 Showcase Quality Program Activities Prepare and maintain documentation evidence of all the quality activities performed Meeting minutes Quality Control/ Quality Monitors Schedules competency assessment, equipment maintenance Event management, corrective & preventative actions Process improvement Internal and external assessment summaries Executive management review & involvement
43 To err is human Event management Process Improvement New process New equipment New procedures
44 Available Resources Professional societies Annual meetings Web site Publications Network with colleagues Ask the experts
45 Professional Organizations AABB (formerly American Association of Blood Banks) American Society for Apheresis (ASFA) American Society of Clinical Pathology (ASCP) College of American Pathologists (CAP) Foundation for the Accreditation of Cellular Therapy (FACT) ICCBBA (formerly International Council for Commonality in Blood Banking Automation) ISBT 128 global standard for label information Blood, Blood Components and Cellular Therapy Products The Joint Commission (TJC) World Apheresis Association (WAA)
46 Web sites AABB accreditation ISBT labeling FACT accreditation CAP accreditation (laboratory) The Joint Commission
47 Web sites Health Insurance Portability and Accountability ACT (HIPAA) U.S. Food and Drug Administration New Hampshire Avenue Silver Spring, MD INFO-FDA ( )
48 Publications Accreditation Standards Federal Government FDA Code of Federal Regulations Guidance Documents State Government Department of Public Health
49 Summary Standards, Guidelines, and Regulations compliance should be viewed as an opportunity for process improvement to protect patients and donors.
50
51 Life is an ever changing landscape. We lay our heads down to rest never knowing what the next day will bring, but for its sunrise and sunset. Among life s joy and content, there are unexpected events that shatter our peace. Life changes in an instant. Yet, in the midst of chaos and confusion, special helpers always emerge. Life s special helpers include our doctors, our nurses, all caregivers and health care workers. You are hear 24 hours a day, every day of the year, never knowing who will be treating and what circumstances will challenge you. Yet, you rise to every occasion. Yet rise to natural disasters and man made ones. You keep calm, draw upon your specialized knowledge and training, are driven by unrelenting passion to help people in their times of need. You guide. You heal. You save lives. Baystate Health extends appreciation to every one of our health care workers and our brothers and sisters in health care throughout our state and nation who also do this every day. We expand our circle of gratitude by honoring all first responders, law enforcement and soldiers who, like health care workers, have an internal calling to selflessly serve. You say you are just doing your job. We say you are doing more than you know. Thank you. May those two words be enough to inspire you to do it again tomorrow.
52 Questions? My Contact
Regulatory,Quality & Emergency Preparedness. MaryBeth Parache Director, Quality Affairs New York Blood Center
Regulatory,Quality & Emergency Preparedness MaryBeth Parache Director, Quality Affairs New York Blood Center 1 Regulatory 2 Who regulates us? Food and Drug Administration (FDA) Blood, tissue, HCT/P, medical
More information7 th Edition FACT-JACIE International Standards for Hematopoietic Cellular Therapy Product Collection, Processing, and Administration
7 th Edition FACT-JACIE International Standards for Hematopoietic Cellular Therapy Product Collection, Processing, and Administration Summary of Changes This document summarizes the major changes made
More informationCELLULAR THERAPY PRODUCT COLLECTION, PROCESSING, AND ADMINISTRATION DOCUMENT SUBMISSION REQUIREMENTS
CELLULAR THERAPY PRODUCT COLLECTION, PROCESSING, AND ADMINISTRATION DOCUMENT SUBMISSION REQUIREMENTS FACT-JACIE International Standards for Cellular Therapy Product Collection, Processing and Administration,
More informationTESTIMONY OF THOMAS HAMILTON DIRECTOR SURVEY & CERTIFICATION GROUP CENTER FOR MEDICAID AND STATE OPERATIONS CENTERS FOR MEDICARE & MEDICAID SERVICES
TESTIMONY OF THOMAS HAMILTON DIRECTOR SURVEY & CERTIFICATION GROUP CENTER FOR MEDICAID AND STATE OPERATIONS CENTERS FOR MEDICARE & MEDICAID SERVICES ON CLIA AND GENETIC TESTING BEFORE THE SENATE SPECIAL
More informationUNIVERSITY OF PENNSYLVANIA HEALTH SYSTEM
Gilead Sciences, Inc. GS-US-248-0123, Amendment 1, 19-JUN-2012 A Long Term Follow-up Registry Study of Subjects Who Did Not Achieve Sustained Virologic Response in Gilead-Sponsored Trials in Subjects with
More informationThe Transfusion Medicine diplomate will respect the rights of the individual and family and must
Competency Portfolio for the Diploma in Transfusion Medicine Guide for AFC-Diploma Committees/Working Groups, Educators 2012 VERSION 1.0 This portfolio applies to those who begin training on or after July
More informationPolicy Subject Index Number Section Subsection Category Contact Last Revised References Applicable To Detail MISSION STATEMENT: OVERVIEW:
Subject Objectives and Organization Pathology and Laboratory Medicine Index Number Lab-0175 Section Laboratory Subsection General Category Departmental Contact Ekern, Nancy L Last Revised 10/25/2016 References
More informationQualification In Apheresis. Chrissy Anderson, BSN, RN, HP (ASCP) ASFA Annual Meeting Review Workshop May 3, 2016
Qualification In Apheresis Chrissy Anderson, BSN, RN, HP (ASCP) ASFA Annual Meeting Review Workshop May 3, 2016 STRATEGIC PLAN 2014-2017 STRATEGIC DIRECTION #2: EDUCATION The purpose of this strategic
More informationQuality Management of Apheresis Personnel
In: McLeod BC, Price TH, Weinstein R, eds. Apheresis: Principles and Practice, 2nd Edition Bethesda, MD: AABB Press, 2003 Quality Management of Apheresis Personnel 32 Quality Management of Apheresis Personnel
More informationCAP Most Frequent Deficiencies and How to Avoid Them. March 11, 2015
CAP 2015 Most Frequent Deficiencies and How to Avoid Them Jean Ball MBA,MT(HHS),MLT(ASCP) Inspection Services Team Lead Laboratory Accreditation Program March 11, 2015 Objectives: Participants will be
More informationNational Marrow Donor Program /Be the Match 23rd Edition Standards And Glossary January 1, 2016 Notice and Disclaimer NMDP/Be the Match Standards
National Marrow Donor Program /Be the Match 23rd Edition Standards And Glossary January 1, 2016 Notice and Disclaimer NMDP/Be the Match Standards These standards apply to activities performed by National
More informationChanges to QSR. The table below provides a history of changes to FDA s Quality System Regulation (QSR)
Changes to QSR The table below provides a history of changes to FDA s Quality System Regulation (QSR) The citation is to the Federal R: the first number is the volume, FR indicates the Federal Register,
More informationPrepublication Requirements
Issued Prepublication Requirements The Joint Commission has approved the following revisions for prepublication. While revised requirements are published in the semiannual updates to the print manuals
More informationList of Policies and Standard Operational Procedures (SOPs) for cell collection, processing and transplantation programmes
Format of SOPs (SOPs) for cell collection, processing and transplantation programmes There must be an SOP covering the procedure of preparing, implementing and revising all procedures and an SOP for document
More informationHIPAA PRIVACY TRAINING
HIPAA PRIVACY TRAINING HIPAA Privacy Training Objective Present a general overview of HIPAA and define important terms Understand the purpose of HIPAA and the Privacy Rule Understand the term Protected
More informationFACT (Foundation for the Accreditation of Cellular Therapy): Elizabeth Perry, MD
FACT (Foundation for the Accreditation of Cellular Therapy): An Inspector s View Elizabeth Perry, MD 11/7/08 Standards FACT-JACIE International Standards for Cellular Therapy Product Collection, Processing,
More informationQuality Medical and Laboratory Practice in Cellular Therapy
Quality Plans: Development and Implementation ISCT Annual Meeting May 24, 2010 Lizette Caballero, B.S., M.T.(ASCP) Laboratory Manager Florida Hospital Cellular Therapy Laboratory Quality Plan: Development
More informationNANCI A. HAYWARD North Springs Drive Dunwoody, Georgia
1595 North Springs Drive Dunwoody, Georgia 30338 404-502-2823 nancihayward@thedragonflysolution.com Summary Over 25 years of team building, goal oriented management, and direct industrial experience using
More information5 th Edition FACT-JACIE International Standards for Cellular Therapy Product Collection, Processing, and Administration Summary of Changes
5 th Edition FACT-JACIE International Standards for Cellular Therapy Product Collection, Processing, and Administration Summary of Changes This document summarizes the changes made to the 5 th edition
More informationPersonnel. From RLM, COM, GEN and TLC Checklists
Personnel From RLM, COM, GEN and TLC Checklists The laboratory should have an organizational plan, personnel policies, and job descriptions that define qualifications and duties for all positions. Personnel
More informationSenior Care Pharmacy Wichita
Senior Care Pharmacy Wichita 1402 S.RIDGE ROAD WICHITA, KS, 67209 Phone: 316-945-7455 Fax: 316-945-7457 Contact:- Carol Parsons Dear patient/responsible party, Effective immediately, each patient/responsible
More informationAbout PACT. PACT Members. Production Assistance for Cellular Therapies. October 11, :00 Noon - 1:00 PM ET
Production Assistance for Cellular Therapies Welcome to the PACT Educational Web Seminar October 11, 2007 12:00 Noon - 1:00 PM ET About PACT An NHLBI-funded initiative committed to the advancement of effective
More informationHealth Science Career Cluster (HL) Therapeutic Services - Patient Care Career Pathway (HL-THR) 13 CCRS CTE
Health Science Career Cluster (HL) 1. Determine academic subject matter, in addition to high school graduation requirements, necessary for pursuing a health science career. 2. Explain the healthcare worker
More information6/28/2016. Questions? Workshop 6 CAP Inspection Preparation Thursday, June 23, 2016
Workshop 6 CAP Inspection Preparation Thursday, June 23, 2016 Allan W. Fraser Jr., CG(ASCP)CM, CCS, CQA(ASQ) Quality Assurance Manager, Quest Diagnostics at Nichols Institute Questions? Have you been inspected
More informationHOSPICE CONTRACTING CHECKLIST FOR INPATIENT SERVICES, RESPITE CARE AND VENDOR AGREEMENTS
HOSPICE CONTRACTING CHECKLIST FOR INPATIENT SERVICES, RESPITE CARE AND VENDOR AGREEMENTS The following checklist can be used to verify that the regulatory requirements are addressed in hospice contracts
More informationNew Patient Information
New Patient Information PATIENT INFORMATION M / F Last Name First Name Middle Name Suffix- Jr, Sr, etc. Mr, Mrs, Ms, Dr Sex Date of Birth Social Security Number Alias- Nickname (Last, First, Middle) Permanent
More informationCE Update [generalist compliance/regulation management/administration and training] COLA Accreditation An Educational Experience
your lab focus 284 CE Update [generalist compliance/regulation management/administration and training] COLA Accreditation An Educational Experience Jennifer L. Rivers, Catherine M. Johnson, MT(ASCP) COLA,
More informationAMERICAN BOARD OF HISTOCOMPATIBILITY AND IMMUNOGENETICS Laboratory Director. Content Outline
1. Administration and Management (40 Items) A. Quality Assurance (16 items) 1. Determine if technical staff has received training and continuing education 2. Select external laboratory proficiency testing
More informationScope of Service. Department Mission
Scope of Service Department Mission Scope of Services Provided The Department of Laboratory Services provides a wide array of testing and other services to Memorial Health System s patients, and to other
More informationCOMMISSION ON LABORATORY ACCREDITATION. Laboratory Accreditation Program TEAM LEADER ASSESSMENT OF DIRECTOR & QUALITY CHECKLIST
Revised: 09/27/2007 COMMISSION ON LABORATORY ACCREDITATION Laboratory Accreditation Program TEAM LEADER ASSESSMENT OF DIRECTOR & QUALITY CHECKLIST Disclaimer and Copyright Notice The College of American
More informationStandards for Laboratory Accreditation
Standards for Laboratory Accreditation 2017 Edition cap.org 2017 College of American Pathologists. All rights reserved. [ T y p e t h e c o m p a n y a d d r e s s ] CAP Laboratory Accreditation Program
More informationCLIA S NEW IQCP SEABB. March 19, Linda Sigg, MT(ASCP)SBB,CQA(ASQ) Staff Lead Assessor, Accreditation, AABB
CLIA S NEW IQCP SEABB March 19, 2014 Linda Sigg, MT(ASCP)SBB,CQA(ASQ) Staff Lead Assessor, Accreditation, AABB OBJECTIVES Clinical Laboratory Improvement Amendment What is IQCP? What are the parts of IQCP.
More informationMEETING. of Transfusion Service Information
Second Integration Annual or Pathology Disintegration All Staff MEETING of Transfusion Service Information Suzanne H. Butch, MLS(ASCP) CM, SBB CM, DLM CM University of Michigan Hospitals and Health Centers
More informationFamily Cord Blood and Cord Tissue Banking Enrollment Documents Services Agreement
Family Cord Blood and Cord Tissue Banking Enrollment Documents Services Agreement The undersigned expectant parent(s) ( Client ) are electing to enter into the Services Agreement ( Agreement ) for CORD:USE
More informationGuidance for Industry ANDA Submissions Prior Approval Supplements Under GDUFA
Guidance for Industry ANDA Submissions Prior Approval Supplements Under GDUFA DRAFT GUIDANCE This guidance document is being distributed for comment purposes only. Comments and suggestions regarding this
More informationImproving Your POC Program: An Upside Down Map. Sheila K. Coffman MT(ASCP)
Improving Your POC Program: An Upside Down Map Sheila K. Coffman MT(ASCP) If you have seen ONE Point of Care program You have seen ONE Point of Care Program. If only there was a MapQuest for POC... Or
More informationCHI Mercy Health. Definitions
CHI Mercy Health Definitions If you have any questions about this notice, please contact the CHI Mercy Health s Privacy Office at (701) 845-6540 or 570 Chautauqua Blvd, Valley City ND 58072. Notice of
More informationStandard Of Nursing Care During Blood Transfusion
Standard Of Nursing Care During Blood Transfusion Blood transfusion carries potentially serious hazards. Nurses Observations that should be carried out before, during and after a transfusion SHOT aims
More informationCLINICAL FELLOWSHIP PROGRAM IN TRANSFUSION MEDICINE
CLINICAL FELLOWSHIP PROGRAM IN TRANSFUSION MEDICINE The Department of Pathology and Laboratory Medicine University of Alberta, Faculty of Medicine and Dentistry and Alberta Health Services CLINICAL FELLOWSHIP
More informationPROGRAM GUIDE - UNIVERSITY CLIA REGISTERED LABORATORIES COMPLIANCE COMMITTEE
PROGRAM GUIDE - UNIVERSITY CLIA REGISTERED LABORATORIES COMPLIANCE COMMITTEE 1 P age GUIDELINES - UNIVERSITY CLIA REGISTERED LABORATORIES COMPLIANCE COMMITTEE AND PROGRAM I. Introduction II. Committee
More informationStudy Management PP STANDARD OPERATING PROCEDURE FOR Safeguarding Protected Health Information
PP-501.00 SOP For Safeguarding Protected Health Information Effective date of version: 01 April 2012 Study Management PP 501.00 STANDARD OPERATING PROCEDURE FOR Safeguarding Protected Health Information
More informationCAH PREPARATION ON-SITE VISIT
CAH PREPARATION ON-SITE VISIT Illinois Department of Public Health, Center for Rural Health This day is yours and can be flexible to the timetable of hospital staff. An additional visit can also be arranged
More informationPRE-INSPECTION QUESTIONNAIRE INSTRUCTIONS
PRE-INSPECTION QUESTIONNAIRE INSTRUCTIONS! Submit copies of all documents or records outlined below. If you do not have the required information, indicate whether or not you expect to have it at the time
More informationCMS HOSPITAL CONDITIONS OF PARTICIPATION (COPS) 2011
CMS HOSPITAL CONDITIONS OF PARTICIPATION (COPS) 2011 What Hospitals Need to Know About Grievances Speaker Sue Dill Calloway RN, Esq. CPHRM AD, BA, BSN, MSN, JD President Patient Safety and Education 5447
More informationMLT 215 CLINICAL PRACTICE COURSE OUTLINE. Pre requisites: MLT 112, 200, 207, 212 & 214
MLT 215 CLINICAL PRACTICE COURSE OUTLINE Hours: Clinical lab practice 14 weeks/560 hours Pre requisites: MLT 112, 200, 207, 212 & 214 Credits: 10 Catalog description: Clinical practice takes place in an
More informationTRAINING. A. Hazard Communication/Right-to-Know Training
XIII. TRAINING A multitude of training requirements are addressed by OSHA and other safety, health and environmental regulations. A summary of these requirements are presented. A. Hazard Communication/Right-to-Know
More informationBIMO SITE AUDIT CHECKLIST
Item AUTHORITY AND ADMINISTRATION FOR STUDIES INVOLVING HUMAN DRUGS, BIOLOGICS AND DEVICES 1. Compare the Investigator Agreement with the information provided by the assigning Center. Auditor will check
More informationI. Preamble: II. Parties:
I. Preamble: MEMORANDUM OF UNDERSTANDING BETWEEN THE FEDERAL COMMUNICATIONS COMMISSION AND THE FOOD AND DRUG ADMINISTRATION CENTER FOR DEVICES AND RADIOLOGICAL HEALTH The Food and Drug Administration (FDA)
More informationTo: Prefectural Governors From: Director General, Pharmaceutical and Food Affairs Bureau, Ministry of Health, Labour and Welfare
This draft English translation of notification on GLP has been made by JSQA. JSQA translated them with particular care to accuracy, but does not guarantee that there are no differences in the delicate
More informationBlood Bank Rotations Goals and Objectives. Rotation Director: Robertson Davenport, M.D.
Blood Bank Rotations Goals and Objectives Rotation Director: Robertson Davenport, M.D. The goal of the First Blood Bank Rotation is for the resident to move from being a Novice (A novice knows little about
More informationINFORMED CONSENT FOR TREATMENT
INFORMED CONSENT FOR TREATMENT I (name of patient), agree and consent to participate in behavioral health care services offered and provided at/by Children s Respite Care Center, a behavioral health care
More informationSafe and Healthy Tissue Implants
Safe and Healthy Tissue Implants Every year, LifeNet Health distributes over 400,000 allograft bio-implants to meet the urgent needs of hospitals and patients around the world. Our record of safety is
More informationCompounded Sterile Preparations Pharmacy Content Outline May 2018
Compounded Sterile Preparations Pharmacy Content Outline May 2018 The following domains, tasks, and knowledge statements were identified and validated through a role delineation study. The proportion of
More informationWhat s New and Improved for the Laboratory Program in 2013 April 23, 2013
What s New and Improved for the Laboratory Program in 2013 April 23, 2013 John Gibson MA, MT(ASCP), DLM Associate Director Standards Interpretation Group Stacy Olea MBA, MT(ASCP), FACHE Field Director
More informationBalance Fitness and Nutrition
Balance Fitness and Nutrition HIPPA Notice of Privacy Practices Effective Date: January 29, 2012 THIS NOTICE DESCRIBES HOW PROTECTED HEALTH INFORMATION ABOUT YOU MAY BE USED AND DISCLOSED AND HOW YOU CAN
More informationUS ): [42CFR ]:
GEN.53400 Section Director (Technical Supervisor) Qualifications/Responsibilities Phase II Section Directors/Technical Supervisors meet defined qualifications and fulfill the expected responsibilities.
More informationWORLD MARROW DONOR ASSOCIATION WMDA INTERNATIONAL STANDARDS FOR UNRELATED HAEMATOPOIETIC STEM CELL DONOR REGISTRIES
1 of 23 pages World Marrow Donor Association International Standards for Unrelated Haematopoietic Stem Cell Donor Registries Document type WMDA Standards 2017 WG/Committee BCST Document reference Approved
More informationFinancial Disclosure. Learning Objectives: Preventing and Responding to Sentinel Events in Surgery 10/13/2015
Preventing and Responding to Sentinel Events in Surgery Beverly Kirchner, BSN, RN, CNOR, CASC April 2014 Financial Disclosure I DO NOT have an actual, potential or perceived conflict of interest to disclose
More informationPatient Registration Form Pediatrics
Patient Registration Form Pediatrics For Office Use Only: Visit Date: Initials: PATIENT INFORMATION Preferred Language: English Spanish Other: Patient s Last Name First Middle Initial Date of Birth Sex
More informationBest Practices for Equipment Calibration and Analytical Controls in the Diagnostics Laboratory
Best Practices for Equipment Calibration and Analytical Controls in the Diagnostics Laboratory George Rodrigues, Artel (slides 2-16) Rebecca Butler, CareDx (slides 17-29) Agenda Agenda Theory / Regulations
More informationCore Competencies. for the Clinical Transplant Coordinator
Core Competencies for the Clinical Transplant Coordinator Assumption Statements This document outlines the core competencies for practitioners/coordinators in the field of clinical transplantation. These
More informationHealthStream Ambulatory Regulatory Course Descriptions
This course covers three related aspects of medical care. All three are critical for the safety of patients. Avoiding Errors: Communication, Identification, and Verification These three critical issues
More informationLaboratory Risk Assessment: IQCP and Beyond. Ron S. Quicho, MS Associate Project Director Standards and Survey Methods, Laboratory July 18, 2017
Laboratory Risk Assessment: IQCP and Beyond Ron S. Quicho, MS Associate Project Director Standards and Survey Methods, Laboratory July 18, 2017 Objectives Explain the importance of risk assessment in the
More informationEffective Date: 11/09 Policy Chronicle:
Title: Investigational Drug Service Functions Policy Type: Clinical Operations Replaces (supersedes): Title: N/A Policy Chronicle: Date Original Version of Policy was Effective: 09/06 Reviewer Signature:
More informationHIPAA Notice of Privacy Practices
HIPAA Notice of Privacy Practices *HIPAA: Health Insurance Portability and Accountability Act Effective Date: April 14, 2003; rev. Dec. 1, 2003; Form # 030463 CAT: 15-Patient Data To reorder, log onto
More informationAccreditation and Certification. Dorothy Dupree, Acting Director Margaret Brady, Quality Management Phoenix Area
Accreditation and Certification Dorothy Dupree, Acting Director Margaret Brady, Quality Management Phoenix Area 1 QUALITY PROCESS PYRAMID 2 Base Level 3 Medicare Conditions of Participation Compliance
More informationFREQUENTLY ASKED QUESTIONS
FREQUENTLY ASKED QUESTIONS What does ispecimen do? Privately held and headquartered in Lexington, MA, ispecimen is a trusted, one-stop source of customized human biospecimen collections. Every day at hospitals
More informationASTS HRSA JCAHO NATO American Society of Transplantation. Disclosure. UNOS/CMS Regulations
Disclosure UNOS/CMS Regulations I have no relevant financial or nonfinancial relationships to disclose Laura Murdock-Stillion, MHA, FACHE The Ohio State University Wexner Medical Center The Regulatory
More informationJoint Commission International Accreditation Standards for Hospitals. Including Standards for Academic Medical Center Hospitals
Joint Commission International Accreditation Standards for Hospitals Including Standards for Academic Medical Center Hospitals 6th Edition Effective 1 July 2017 Section I: Accreditation Participation Requirements
More informationOpp Health and Rehabilitation, LLC 115 Paulk Avenue P.O. Box 730 Opp, AL Phone Number: (334)
Opp Health and Rehabilitation, LLC 115 Paulk Avenue P.O. Box 730 Opp, AL 36467-1695 Phone Number: (334) 493-4558 THIS NOTICE DESCRIBES HOW MEDICAL INFORMATION ABOUT YOU MAY BE USED AND DISCLOSED AND HOW
More informationNOTE: The first appearance of terms in bold in the body of this document (except titles) are defined terms please refer to the Definitions section.
TITLE TRANSFUSION OF BLOOD COMPONENTS AND PRODUCTS SCOPE Provincial APPROVAL AUTHORITY Clinical Operations Executive Committee SPONSOR Provincial Transfusion Medicine Network Not applicable DOCUMENT #
More informationPre-inspection documentation
Pre-inspection documentation Introduction... 1 Language... 1 Pre-formatted folder structure... 2 When do I have to send these document?... 2 What does JACIE do with these documents?... 2 How does JACIE
More informationELECTIVE COMPETENCY AREAS, GOALS, AND OBJECTIVES FOR POSTGRADUATE YEAR ONE (PGY1) PHARMACY RESIDENCIES
ELECTIVE COMPETENCY AREAS, GOALS, AND OBJECTIVES FOR POSTGRADUATE YEAR ONE (PGY1) PHARMACY RESIDENCIES Introduction The competency areas, goals, and objectives are for use with the ASHP Accreditation Standard
More informationHIC Standard Operating Procedure. For-Cause Audits of Human Research Studies
HIC Standard Operating Procedure For-Cause Audits of Human Research Studies Background As part of the Wayne State University (WSU) Human Investigation Committee s (HIC) Human Research Protection Program,
More informationPatient Blood Management Certification Revisions
Issued October 3, 07 Patient Blood Management Certification Revisions Patient Blood Management (PBM) Certification Program Assessments: Internal and External (PBMAM) Chapter Standard PBMAM. The program
More informationOfficial Journal of the European Union
L 33/30 DIRECTIVE 2002/98/EC OF THE EUROPEAN PARLIAMT AND OF THE COUNCIL of 27 January 2003 setting standards of quality and safety for the collection, testing, processing, storage and distribution of
More informationPATIENT INFORMATION. In Case of Emergency Notification
PATIENT INFORMATION Patient Name Date Nickname DOB Age Sex Race/Ethnicity Language(s) spoken at home Person completing form Relation to Patient Patient Address City State Zip Phone # Other Phone Medical
More informationJOB DUTIES AND RESPONSIBILITIES
JOB DESCRIPTION Job Title: Reports to: Resource Triage Coordinator Director, Operations Center Prepared By: Approved By: Human Resources VP of HR FLSA Status: Non-Exempt Date: May 2018 Donor Network West
More informationNEW BRIGHTON CARE CENTER
NEW BRIGHTON CARE CENTER 805 6 th Ave NW, New Brighton, MN 55112 NOTICE OF PRIVACY PRACTICES THIS NOTICE DESCRIBES HOW MEDICAL INFORMATION ABOUT YOU MAY BE USED AND DISCLOSED AND HOW YOU CAN GET ACCESS
More informationFederal Register / Vol. 72, No. 61 / Friday, March 30, 2007 / Rules and Regulations
Federal Register / Vol. 72, No. 61 / Friday, March 30, 2007 / Rules and Regulations 15273 under this final rule, all transplant centers must be re-approved every 3 years, and some centers will be surveyed
More informationNOTICE OF PRIVACY PRACTICES Occupations, Inc. 15 Fortune Road West Middletown, NY 10941
NOTICE OF PRIVACY PRACTICES Occupations, Inc. 15 Fortune Road West Middletown, NY 10941 THIS NOTICE DESCRIBES HOW MEDICAL INFORMATION ABOUT YOU MAY BE USED AND DISCLOSED AND HOW YOU CAN GET ACCESS TO THIS
More information(i) That individual is competent to provide nursing and nursing related services; and
483.75 Administration. A facility must be administered in a manner that enables it to use its resources effectively and efficiently to attain or maintain the highest practicable physical, mental, and psychosocial
More informationTexas Medicaid. Provider Procedures Manual. Provider Handbooks. Telecommunication Services Handbook
Texas Medicaid Provider Procedures Manual Provider Handbooks December 2017 Telecommunication Services Handbook The Texas Medicaid & Healthcare Partnership (TMHP) is the claims administrator for Texas Medicaid
More informationPatient Blood Management Certification Program. Review Process Guide. For Organizations
Patient Blood Management Certification Program Review Process Guide For Organizations 2018 What's New in 2018 Updates effective in 2018 are identified by underlined text in the activities noted below.
More informationInternal Lab Inspections: Are You Inspection Ready? Presented by: Jeanne Mumford, MT(ASCP) Manager, Point of Care Testing, JHM
Internal Lab Inspections: Are You Inspection Ready? Presented by: Jeanne Mumford, MT(ASCP) Manager, Point of Care Testing, JHM Speaker Introductions Jeanne Mumford, MT(ASCP) Manager, Point of Care Testing
More informationCMS OASIS Q&As: CATEGORY 2 - COMPREHENSIVE ASSESSMENT
CMS OASIS Q&As: CATEGORY 2 - COMPREHENSIVE ASSESSMENT Q1. When are we required to collect OASIS? [Q&A EDITED 06/14] A1. The Condition of Participation (CoP) published in January 1999 requires a comprehensive
More informationSTANDARDS Point-of-Care Testing
STANDARDS Point-of-Care Testing For Surveys Starting After: January 1, 2018 Date Generated: January 12, 2017 Point-of-Care Testing Published by Accreditation Canada. All rights reserved. No part of this
More informationPATIENT ADMISSIONS 2.0
PATIENT ADMISSIONS 2.0 HOSPITAL DIVISION FINANCIAL POLICIES and PROCEDURES MANUAL SECTION 2.0 PATIENT ADMISSIONS 2.4 Admissions General Information Patient Classification Inpatient An inpatient is a person
More informationCINCINNATI CHILDREN S HOSPITAL MEDICAL CENTER CONSENT TO PARTICIPATE IN A RESEARCH STUDY
CINCINNATI CHILDREN S HOSPITAL MEDICAL CENTER CONSENT TO PARTICIPATE IN A RESEARCH STUDY STUDY TITLE: The International Diffuse Intrinsic Pontine Glioma (DIPG) Registry and Repository SPONSOR NAME: Maryam
More informationThe CLIA regulations..
Julia H. Appleton MT(ASCP), MBA Centers for Medicare & Medicaid Services (CMS) Center for Clinical Standards and Quality (CCSQ) Division of Laboratory Services (DLS) April 13, 2017 Objectives Explain an
More informationCIO Legislative Brief
CIO Legislative Brief Comparison of Health IT Provisions in the Committee Print of the 21 st Century Cures Act (dated November 25, 2016), H.R. 6 (21 st Century Cures Act) and S. 2511 (Improving Health
More informationJOB DESCRIPTION. Mission Asante exists to provide quality healthcare services in a compassionate manner, valued by the communities we serve.
Entity ROGUE VALLEY MEDICAL CENTER Department RVMC PCS - Surgery Job Code 845 Job Title INFORMATICS RN Description Date 01/09/2004 JOB DESCRIPTION Mission Asante exists to provide quality healthcare services
More informationHeart of America POC Group Quality Management Making it Meaningful
Heart of America POC Group Quality Management Making it Meaningful Maximize Your Existing Quality Management System to Deliver Greater Value Georgine Paulus, BSMT(ASCP) Senior Staff Inspector College of
More informationCLIA Regulations Update 2015
Regulations Update 2015 1 KAREN DYER MT(ASCP), DLM ACTING DIRECTOR DIVISION OF LABORATORY SERVICES CENTERS FOR MEDICARE&MEDICAID SERVICES Learning Objectives Understand the impact of the Patient Access
More informationINTERNATIONAL STANDARDS FOR CELLULAR THERAPY PRODUCT COLLECTION, PROCESSING, AND ADMINISTRATION
INTERNATIONAL STANDARDS FOR CELLULAR THERAPY PRODUCT COLLECTION, PROCESSING, AND ADMINISTRATION Third Edition NOTICE These Standards are designed to provide minimum guidelines for facilities and individuals
More informationSJN DO CB Field Alert Reports. Edwin Ramos Director of Compliance Food and Drug Administration San Juan District Office
SJN DO CB Field Alert Reports Edwin Ramos Director of Compliance Food and Drug Administration San Juan District Office SJN DO Mission Assuring that safe and effective drugs are available to the public
More informationCAP Forensic Drug Testing Accreditation Program Standards for Accreditation
CAP Forensic Drug Testing Accreditation Program Standards for Accreditation Preamble Forensic drug testing is a laboratory specialty concerned with the testing of urine, oral fluid, hair, and other specimens
More informationDRAFT GUIDANCE This guidance document is being distributed for comment purposes only. Document issued on: August 5, 2008
Draft Guidance for HDE Holders, Institutional Review Boards (IRBs), Clinical Investigators, and FDA Staff Humanitarian Device Exemption (HDE) Regulation: Questions and Answers DRAFT GUIDANCE This guidance
More informationSubmitting Requests for Exemption and Expedited Review to the IRB
Submitting Requests for Exemption and Expedited Review to the IRB Tufts-New England Medical Center Tufts University Health Sciences IRB Education Series 2006 Presentation may only be reused or reprinted
More informationImplementing the Revised Common Rule Exemptions with Limited IRB Review
Implementing the Revised Common Rule Exemptions with Limited IRB Review Introduction: Four of the exempt categories in the revised Common Rule include a provision for limited IRB review. This resource
More information